生命科学解决方案提供商Azenta, Inc. 已签署具有约束力的最终协议，将其B Medical Systems业务板块整体出售给欧洲私募股权公司Thelema S.À R.l.。此次交易标志着Azenta战略转型的关键一步，旨在优化业务组合并聚焦核心增长领域。
B Medical Systems作为全球领先的冷链解决方案供应商，长期专注于疫苗冷藏箱、血液储存设备及温度监测系统的研发制造。该剥离决定符合Azenta强化主营业务竞争力的长期规划，交易完成后将显著提升公司资本配置效率。
根据协议条款，Thelema S.À R.l.将通过现金方式完成收购，具体交易金额未予披露。双方预计在满足常规交割条件后，于2024财年第三季度完成资产移交。此次业务剥离不会影响Azenta现有客户的服务连续性，相关团队将平稳过渡至新所有权架构下。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.